Active

1)     National Institute of Allergy/Infectious Diseases, 2R01AI050050-05A1, February 1 of 2006 to January 31 of 2011.  Project title: “Structural specificity of heparan sulfate for herpes infection” (Principal Investigator).  Direct cost $226,000/yr for five years, 15% effort.

2)     National Heart, Lung and Blood Institute. 1R01HL094463-01, February 13 of 2009 to January 31 of 2013.  Project title: “In vitro synthesis of recombinant heparan sulfate” (Principal Investigator).  Direct cost $286,000/yr for 4 years, 15% effort.

3)     National Institute of Allergy/Infectious Diseases, 3R01AI050050-07S1, February 1 of 2008 to January 31 of 2011.  Project title: “Structural specificity of heparan sulfate for herpes infection” (Principal Investigator).  Direct cost $33,000/yr for three years.  This grant is to support Ms. Courtney Jones’ PhD studies.

4)     National Heart, Lung, and Blood Institute, 3R01HL094463-01S1, July 1 of 2009 to January 31 of 2013.  Project title: “In vitro synthesis of recombinant heparan sulfate” (Principal Investigator).  Direct cost $33,961/yr.  This grant is to support Ms. Priscilla Paul’s PhD studies.

5)     National Institute of Allergy/Infectious Diseases, 1R21AI074775-01A2, August 1 of 2009 to July 31 of 2011.  Project title: “Glycomics of Heparan Sulfate in Bacterial Pathogenesis” (Principal Investigator).  Direct cost, $150,000/yr1 and $125,000/yr2, 10% effort.

6)     National Heart, Lung and Blood Institute. 1R01HL096972-01, August 1 of 2009 to April 30 of 2014.  Project title: “Development of a Bioengineered Heparin from a Non-Animal Source” (Principal Investigator, Robert J Linhardt).  Role in the project: Co-PI.  Direct cost $100,000/yr for Yr 1-Yr3 and $75,000/yr for Yr4-Yr5, 5% effort.

7)     National Institute of Allergy/Infectious Diseases, 3R01AI050050, September 18 of 2009 to August 31 of 2010.  Project title: “Structural specificity of heparan sulfate for herpes infection” (Principal Investigator).  Direct cost $99,760.  This grant is to purchase a LC/MS system.

8)      National Institute of General Medical Sciences, 1R01GM090257-01, September 30 of 2009 to August 31 of 2011.  Project title: “An artificial Golgi: Controlled GAG synthesis and screening” (Principal Investigator, Robert J Linhardt).  Role in the project: Co-PI.  Direct cost $55,000/yr1 and $65,000/yr 2, 3% effort.

9)      National Institute of Allergy/Infectious Diseases, 3R01AI50050-9S1, May 17 of 2009 to September 30 of 2010.  Project title: “Structural specificity of heparan sulfate for herpes infection” (Principal Investigator).  Direct cost $5,029.  This grant is to support the summer research training for Mrinalini Ramanan.

10) National Institute of General Medical Sciences, 1R01GM072667-06, June 1 of 2010 to May 30 of 2014.  Project title: “Chemoenzymatic synthesis of heparan sulfate oligosaccharides- subcontract” (Principal Investigator, Xuefei Huang).  Role in the project: Co-PI.  Direct cost $60,000/yr for four years, 4% effort.

11) National Institute of General Medical Sciences, 1R01GM093131-01, May 1 of 2010 to April 30 of 2014.  Project title: “STRUCTURE AND FUNCTION OF 3-O-SULFATION IN HEPARAN SULFATE” (Principal Investigator, Jeff Esko).  Role in the project: Co-PI.  Direct cost $16,000/yr for two years, 3% effort.

12) National Science Foundation, CHE-1111550, July 1 of 2011 to June 30 of 2014.  Project title: “Synthesis of homogeneous heparan sulfate proteoglycans” (Principal Investigator, Xuefei Huang).  Role in the project: Co-PI.  Direct cost $29,000/yr for three years, 3% effort.